ADR · CUSIP 37733W204 · who reports it, how much, and how much it matters to them
28 of the 720 hedge fund managers we track reported shares of GSK plc (NYSE: GSK) on Form 13F for 30 June 2026. Between them they reported USD 675m. The largest position belongs to Grantham Mayo Van Otterloo & Co, at USD 189m. The manager with the most riding on it is Sio Capital Management, where it is 3.8% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Grantham Mayo Van Otterloo & Co1 fund on PPLI.com | USD 189m | 0.4% |
| 2 | POINT72 Asset Management17 funds on PPLI.com | USD 139m | 0.2% |
| 3 | D. E. Shaw & Co.15 funds on PPLI.com | USD 53m | 0.0% |
| 4 | LMR Partners2 funds on PPLI.com | USD 51m | 0.2% |
| 5 | Callodine Capital Management1 fund on PPLI.com | USD 51m | 3.4% |
| 6 | Bridgewater Associates45 funds on PPLI.com | USD 26m | 0.1% |
| 7 | Eversept Partners3 funds on PPLI.com | USD 25m | 1.3% |
| 8 | Sio Capital Management4 funds on PPLI.com | USD 23m | 3.8% |
| 9 | Capricorn Fund Managers8 funds on PPLI.com | USD 22m | 1.8% |
| 10 | Walleye Capital8 funds on PPLI.com | USD 21m | 0.1% |
| 11 | Armistice Capital1 fund on PPLI.com | USD 16m | 0.2% |
| 12 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 10m | 0.0% |
| 13 | Boothbay Fund Management2 funds on PPLI.com | USD 8.2m | 0.1% |
| 14 | Citadel Advisors32 funds on PPLI.com | USD 7.9m | 0.0% |
| 15 | Stamos Capital Partners21 funds on PPLI.com | USD 6m | 0.9% |
| 16 | Sphera Funds Management1 fund on PPLI.com | USD 5.3m | 0.7% |
| 17 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 4.4m | 0.2% |
| 18 | Two Sigma Investments35 funds on PPLI.com | USD 3.7m | 0.0% |
| 19 | Squarepoint Ops7 funds on PPLI.com | USD 3m | 0.0% |
| 20 | Aquatic Capital Management3 funds on PPLI.com | USD 2.3m | 0.1% |
| 21 | Verition Fund Management3 funds on PPLI.com | USD 2.2m | 0.0% |
| 22 | Marshall Wace LLP84 funds on PPLI.com | USD 1.2m | 0.0% |
| 23 | CIBC Asset Management69 funds on PPLI.com | USD 1.1m | 0.0% |
| 24 | Jain Global1 fund on PPLI.com | USD 867,000 | 0.0% |
| 25 | Entrypoint Capital1 fund on PPLI.com | USD 348,000 | 0.1% |
| 26 | Whetstone Capital Advisors2 funds on PPLI.com | USD 250,000 | 0.1% |
| 27 | Corient Ia11 funds on PPLI.com | USD 104,000 | 0.1% |
| 28 | Summit Global Investments1 fund on PPLI.com | USD 1,093 | 0.1% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Sio Capital Management | USD 23m | 3.8% |
| 2 | Callodine Capital Management | USD 51m | 3.4% |
| 3 | Capricorn Fund Managers | USD 22m | 1.8% |
| 4 | Eversept Partners | USD 25m | 1.3% |
| 5 | Stamos Capital Partners | USD 6m | 0.9% |
| 6 | Sphera Funds Management | USD 5.3m | 0.7% |
| 7 | Grantham Mayo Van Otterloo & Co | USD 189m | 0.4% |
| 8 | Campbell & Company Investment Adviser | USD 4.4m | 0.2% |
| 9 | LMR Partners | USD 51m | 0.2% |
| 10 | Armistice Capital | USD 16m | 0.2% |
GSK plc trades under the symbol GSK on the New York Stock Exchange. Its CUSIP, the code used on Form 13F, is 37733W204.
28 of the 720 hedge fund managers PPLI.com tracks reported GSK plc shares on Form 13F for 30 June 2026. The largest reported positions were held by Grantham Mayo Van Otterloo & Co (USD 189m), POINT72 Asset Management (USD 139m), D. E. Shaw & Co. (USD 53m), LMR Partners (USD 51m) and Callodine Capital Management (USD 51m).
28 managers in our coverage reported it, and between them they run 416 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Sio Capital Management, where the position was 3.8% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with GSK plc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.